↓ Skip to main content

Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model

Overview of attention for article published in BMC Endocrine Disorders, September 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
3 X users

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Low-dose spironolactone ameliorates adipose tissue inflammation and apoptosis in letrozole-induced PCOS rat model
Published in
BMC Endocrine Disorders, September 2022
DOI 10.1186/s12902-022-01143-y
Pubmed ID
Authors

Stephanie E. Areloegbe, Mmenyene U. Peter, Mosunmola B. Oyeleke, Kehinde S. Olaniyi

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 20%
Student > Bachelor 2 13%
Researcher 2 13%
Student > Ph. D. Student 1 7%
Student > Doctoral Student 1 7%
Other 0 0%
Unknown 6 40%
Readers by discipline Count As %
Unspecified 3 20%
Pharmacology, Toxicology and Pharmaceutical Science 3 20%
Nursing and Health Professions 2 13%
Biochemistry, Genetics and Molecular Biology 1 7%
Unknown 6 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 September 2022.
All research outputs
#13,501,152
of 23,292,144 outputs
Outputs from BMC Endocrine Disorders
#309
of 785 outputs
Outputs of similar age
#170,275
of 435,405 outputs
Outputs of similar age from BMC Endocrine Disorders
#12
of 38 outputs
Altmetric has tracked 23,292,144 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 785 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,405 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.